°Ë»ö°á°ú: ÃÑ 30°³ Áß 21 - 34 |
¸íÀÎÆä´ÏÅäÀÎÁ¤100mg(Æä´ÏÅäÀÎ)ÀÇ º´¿ë±Ý±â¿¡ ÇØ´çµÇ´Â Á¦Ç°
Á¦Ç°¸í | ¼ººÐ¸í | ÁÖ¼ººÐÄÚµå | Ç¥ÁØÄÚµå | ÆǸŻç¡ã | °í½Ã¹øÈ£ | Àû¿ëÀÏ |
ÇÁ¶ó´Ú»çĸ½¶110¹Ð¸®±×·¥(´Ùºñ°¡Æ®¶õ¿¡ÅؽǷ¹ÀÌÆ®¸Þ½Ç»ê¿°)_(0.12683g/1ĸ½¶) | dabigatran etexilate mesylate (as dabigatran etexilate) | 613701ACH | 653501340 | Çѱ¹º£¸µ°ÅÀΰÖÇÏÀÓ(ÁÖ) | 20180088 | 20181102 |
ÇÁ¶ó´Ú»çĸ½¶150¹Ð¸®±×·¥(´Ùºñ°¡Æ®¶õ¿¡ÅؽǷ¹ÀÌÆ®¸Þ½Ç»ê¿°)_(0.17295g/1ĸ½¶) | dabigatran etexilate mesylate (as dabigatran etexilate) | 613702ACH | 653501350 | Çѱ¹º£¸µ°ÅÀΰÖÇÏÀÓ(ÁÖ) | 20180088 | 20181102 |
¸¶ºñ·¿Á¤_(1Á¤) | glecaprevir | 669700ATB | 624900290 | Çѱ¹¾Öºêºñ(ÁÖ) | 20200130 | 20201228 |
¸¶ºñ·¿Á¤_(1Á¤) | pibrentasvir | 669700ATB | 624900290 | Çѱ¹¾Öºêºñ(ÁÖ) | 20200130 | 20201228 |
·ÎºñÅ¥¾ÆÁ¤100¹Ð¸®±×·¥(·Ñ¶óƼ´Õ)_(0.1g/Á¤) | lorlatinib | 699702ATB | 648903620 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20240030 | 20240625 |
·ÎºñÅ¥¾ÆÁ¤25¹Ð¸®±×·¥(·Ñ¶óƼ´Õ)_(25mg/Á¤) | lorlatinib | 699701ATB | 648903610 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20240030 | 20240625 |
ÀÔ·£½ºÁ¤100¹Ð¸®±×·¥(ÆȺ¸½ÃŬ¸³)_(0.1g/1Á¤) | palbociclib | 655203ATB | 648903720 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20180088 | 20181102 |
ÀÔ·£½ºÁ¤125¹Ð¸®±×·¥(ÆȺ¸½ÃŬ¸³)_(0.125g/1Á¤) | palbociclib | 655202ATB | 648903710 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20180088 | 20181102 |
ÀÔ·£½ºÁ¤75¹Ð¸®±×·¥(ÆȺ¸½ÃŬ¸³)_(75mg/1Á¤) | palbociclib | 655201ATB | 648903700 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20180088 | 20181102 |
ÀÔ·£½ºÄ¸½¶75mg(ÆȺ¸½ÃŬ¸³)_(75mg/1ĸ½¶) | palbociclib | 655201ACH | 648902930 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20180088 | 20181102 |
ÀÔ·£½ºÄ¸½¶125mg(ÆȺ¸½ÃŬ¸³)_(0.125g/1ĸ½¶) | palbociclib | 655202ACH | 648902940 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20180088 | 20181102 |
ÀÔ·£½ºÄ¸½¶100mg(ÆȺ¸½ÃŬ¸³)_(0.1g/1ĸ½¶) | palbociclib | 655203ACH | 648902920 | Çѱ¹ÈÀÌÀÚÁ¦¾à(ÁÖ) | 20180088 | 20181102 |
ÆŽº·Îºñµå(´Ï¸£¸¶Æ®·¼ºñ¸£, ¸®Å䳪ºñ¸£)_(30Á¤) | nirmatrelvir | 703500ATB | 648903860 | Çѱ¹ÈÀÌÀÚÁ¦¾à¢ß | 20210113 | 20211230 |
ÆŽº·Îºñµå(´Ï¸£¸¶Æ®·¼ºñ¸£, ¸®Å䳪ºñ¸£)_(30Á¤) | ritonavir | 703500ATB | 648903860 | Çѱ¹ÈÀÌÀÚÁ¦¾à¢ß | 20210113 | 20211230 |